PROTHENA CORPORATION PUBLIC LIMITED COMPANY

PRTA ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $-153.2M $-160.1M $-80.6M $-7.2M $-41.0M $-41.4M $-29.7M
Depreciation & Amortization $3.1M $2.4M $806.0K $743.0K $660.0K $468.0K $391.0K
Depreciation $3.1M $2.4M $800.0K $700.0K $700.0K $500.0K $400.0K
Amortization
Stock-Based Compensation $26.8M $24.9M $10.4M $5.6M $3.1M $6.1M $3.0M
Net Cash from Operating Activities $-131.2M $-116.3M $-58.6M $-683.0K $-32.1M $-42.1M $-19.7M
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities $-3.5M $-16.6M $-1.4M $-499.0K $-535.0K $-1.3M $-595.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $165.4M $153.3M $137.0M $118.1M $84.5M $168.2M $20.3M
Net Change in Cash $77.0M $116.9M $51.8M $124.9M $0
Free Cash Flow
← Newer Page 2 of 2 Older →